Form 4: Select Medical EVP John Saich Granted 100,000 Restricted Shares

Select Medical Holdings Corp. Executive Vice President John A. Saich was granted 100,000 shares of restricted common stock, vesting in 2028.

Summary

• John A. Saich, Executive Vice President of Select Medical Holdings Corp. (SEM), was granted 100,000 shares of common stock.
• The grant date for these restricted shares is July 29, 2025.
• The shares will vest in full on July 29, 2028, which is the third anniversary of the grant date.
• Following this transaction, John A. Saich beneficially owns 758,157 shares of common stock.
• The transaction code 'A' indicates an acquisition, and the price of $0 confirms it was a grant rather than a purchase.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a key executive aligns their long-term interests with the company's performance, indicating management confidence and a commitment to retention. This is generally viewed positively as a routine compensation event.

Positives

• The grant of restricted stock aligns management's interests with long-term shareholder value.
• Increased beneficial ownership by a key executive demonstrates confidence in the company's future.

Negatives

• No immediate cash inflow for the executive from this grant.
• The shares are restricted and subject to a three-year vesting period, meaning they cannot be sold immediately.

Future Outlook

The 100,000 restricted shares granted to John A. Saich are scheduled to vest in full on July 29, 2028.

Industry Context

This filing is a standard insider transaction report (Form 4) detailing a grant of restricted stock to an executive, which is a common practice in executive compensation across various industries to align management incentives with long-term company performance.

Related Party Transactions

• Grant of 100,000 restricted shares to Executive Vice President John A. Saich.

Stakeholder Impact

• Shareholders: Increased alignment of executive interests with long-term shareholder value.
• Employees: May signal stability and commitment from leadership within the company.

Next Steps

• The 100,000 restricted shares are scheduled to vest in full on July 29, 2028.

Key Dates

Recommendation

This Form 4 reports a routine restricted stock grant to an executive, which is a common form of compensation and aligns management interests with long-term shareholder value. It does not contain information significant enough to alter a fundamental investment thesis or warrant a change in recommendation beyond a 'hold' based solely on this filing.

Keywords

Select Medical Holdings Corp, SEM, Form 4, Restricted Stock Grant, Executive Compensation, Insider Ownership, John A. Saich